Below is a link to Acadia’s presentation at the Cowen Summit in the USA today.
WallStreet Webcasting - ACADIA Pharmaceuticals Inc. (wsw.com)
Trofinetide commentary from 22nd min - 36th min, discussing issues around Adverse Events (diarrhoea) for patients during the trial as well as how they are preparing for the launch assuming FDA approval.
Also, the webcast below was linked here at HC recently, and is a 1 hour presentation dated August 2nd re: the FDA’s NDA review process.
RettEd:What Comes Next? The FDA Regulatory Process from NDA to FDA Decision and Beyond- YouTube
Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-19
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1024 | $20.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.53 | 285 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |